These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38504107)

  • 1. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer.
    Bi G; Liang J; Bian Y; Shan G; Huang Y; Lu T; Zhang H; Jin X; Chen Z; Zhao M; Fan H; Wang Q; Gan B; Zhan C
    Nat Commun; 2024 Mar; 15(1):2461. PubMed ID: 38504107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.
    Ou Y; Wang SJ; Li D; Chu B; Gu W
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6806-E6812. PubMed ID: 27698118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.
    Geck RC; Foley JR; Murray Stewart T; Asara JM; Casero RA; Toker A
    J Biol Chem; 2020 May; 295(19):6263-6277. PubMed ID: 32139506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway.
    Wei W; Lu Y; Hu Q; Yin J; Wang Y; Zhang H; Zhao Q; Liu L
    Cell Oncol (Dordr); 2024 Feb; 47(1):321-341. PubMed ID: 37684512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics.
    Zhu Y; Piao C; Zhang Z; Jiang Y; Kong C
    Genomics; 2022 Jan; 114(1):125-137. PubMed ID: 34843906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CISD3 inhibition drives cystine-deprivation induced ferroptosis.
    Li Y; Wang X; Huang Z; Zhou Y; Xia J; Hu W; Wang X; Du J; Tong X; Wang Y
    Cell Death Dis; 2021 Sep; 12(9):839. PubMed ID: 34497268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function.
    Liu L; Guo X; Rao JN; Zou T; Xiao L; Yu T; Timmons JA; Turner DJ; Wang JY
    Am J Physiol Cell Physiol; 2009 Apr; 296(4):C801-10. PubMed ID: 19176757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes.
    Lane DJR; Bae DH; Siafakas AR; Suryo Rahmanto Y; Al-Akra L; Jansson PJ; Casero RA; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2793-2813. PubMed ID: 29777905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters.
    Gao M; Fan K; Chen Y; Zhang G; Chen J; Zhang Y
    J Genet Genomics; 2022 Oct; 49(10):913-926. PubMed ID: 35697272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.
    Gamble LD; Purgato S; Murray J; Xiao L; Yu DMT; Hanssen KM; Giorgi FM; Carter DR; Gifford AJ; Valli E; Milazzo G; Kamili A; Mayoh C; Liu B; Eden G; Sarraf S; Allan S; Di Giacomo S; Flemming CL; Russell AJ; Cheung BB; Oberthuer A; London WB; Fischer M; Trahair TN; Fletcher JI; Marshall GM; Ziegler DS; Hogarty MD; Burns MR; Perini G; Norris MD; Haber M
    Sci Transl Med; 2019 Jan; 11(477):. PubMed ID: 30700572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells.
    Ruiz-Pérez MV; Medina MÁ; Urdiales JL; Keinänen TA; Sánchez-Jiménez F
    J Biol Chem; 2015 Mar; 290(10):6106-19. PubMed ID: 25593318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc-ODC1 nexus.
    Zhang H; Li X; Liu Z; Lin Z; Huang K; Wang Y; Chen Y; Liao L; Wu L; Xie Z; Hou J; Zhang X; Liu H
    Cancer Metab; 2024 Feb; 12(1):7. PubMed ID: 38395945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.
    Murray-Stewart T; Dunworth M; Lui Y; Giardiello FM; Woster PM; Casero RA
    PLoS One; 2018; 13(8):e0202677. PubMed ID: 30138353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin stimulates cell growth, l-arginine transport, and metabolism to polyamines in human proximal tubular cells.
    Ashman N; Harwood SM; Kieswich J; Allen DA; Roberts NB; Mendes-Ribeiro AC; Yaqoob MM
    Kidney Int; 2005 May; 67(5):1878-89. PubMed ID: 15840035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer.
    Saini KK; Chaturvedi P; Sinha A; Singh MP; Khan MA; Verma A; Nengroo MA; Satrusal SR; Meena S; Singh A; Srivastava S; Sarkar J; Datta D
    Redox Biol; 2023 Sep; 65():102833. PubMed ID: 37536085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
    Hogarty MD; Norris MD; Davis K; Liu X; Evageliou NF; Hayes CS; Pawel B; Guo R; Zhao H; Sekyere E; Keating J; Thomas W; Cheng NC; Murray J; Smith J; Sutton R; Venn N; London WB; Buxton A; Gilmour SK; Marshall GM; Haber M
    Cancer Res; 2008 Dec; 68(23):9735-45. PubMed ID: 19047152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadening horizons: the role of ferroptosis in cancer.
    Chen X; Kang R; Kroemer G; Tang D
    Nat Rev Clin Oncol; 2021 May; 18(5):280-296. PubMed ID: 33514910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
    An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
    Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
    Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer.
    Wang Y; Zheng L; Shang W; Yang Z; Li T; Liu F; Shao W; Lv L; Chai L; Qu L; Xu Q; Du J; Liang X; Zeng J; Jia J
    Cell Death Differ; 2022 Nov; 29(11):2190-2202. PubMed ID: 35534546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.